Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis.

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
G G NomikosH C Fibiger

Abstract

This study examined the acute effects of the novel antidepressant drug, bupropion, on extracellular concentrations of dopamine (DA), its metabolites, and the serotonin metabolite 5-HIAA in the striatum and nucleus accumbens using on-line microdialysis in freely moving rats. Bupropion HCl (10, 25, and 100 mg/kg intraperitoneally) increased extracellular striatal DA in a dose- and time-dependent manner; 1 mg/kg did not affect extracellular DA. The maximal response occurred within the first 20 minutes (+76%, +164%, and +443% for each dose, respectively) followed by a gradual decrease to a stable but elevated level for the next 2 hours. This neurochemical response was strongly associated with bupropion-induced stereotyped behavior during the first hour but not during the subsequent 2 hours. Bupropion decreased DOPAC concentrations, increased 5-HIAA, and had variable effects on homovanillic acid (HVA) (decreases with 10 mg/kg and increases with 25 and 100 mg/kg). The increase in extracellular DA after bupropion (25 mg/kg) was blocked by tetrodotoxin and was therefore action-potential-dependent. Bupropion produced similar neurochemical responses in the striatum and the nucleus accumbens. These results suggest that increases in DA tra...Continue Reading

Citations

Feb 4, 2012·Future Medicinal Chemistry·Craig R Rush, William W Stoops
May 3, 2014·International Journal of Impotence Research·M E Hueletl-SotoG Rodríguez-Manzo
Aug 2, 2006·The British Journal of Psychiatry : the Journal of Mental Science·R M PostJ Mintz
Aug 10, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Sonja K Billes, Michael A Cowley
May 13, 2010·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Kazuaki KawauraKazuo Takahama
May 24, 2011·Pharmacological Reports : PR·Barbara Budzyńska, Grażyna Biała
Oct 20, 2007·The Journal of Physiology·Hiroshi HasegawaRomain Meeusen
May 13, 2008·Drug and Alcohol Dependence·Steven ShoptawWalter Ling
Jun 26, 2007·Pharmacology, Biochemistry, and Behavior·Hassan H LópezBenjamin Ragen
Dec 26, 2006·Expert Review of Neurotherapeutics·Kishore M Gadde, Glen L Xiong
Sep 6, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Seiichiro ShimazuFumio Yoneda
Mar 6, 2010·Annals of the New York Academy of Sciences·David V HerinJohn Grabowski
Oct 9, 2012·British Journal of Clinical Pharmacology·Ariadna Forray, Mehmet Sofuoglu
Jun 6, 2009·The International Journal of Biochemistry & Cell Biology·Hugo R Arias
Sep 3, 2013·European Journal of Pharmacology·Tomohisa MoriTsutomu Suzuki
Jun 21, 2014·Journal of Addiction Medicine·Kirsten OppekOliver Pogarell
Aug 1, 1993·Acta Physiologica Scandinavica·L ArboreliusT H Svensson
Mar 30, 2013·Journal of Psychopharmacology·David J HealDavid J Nutt
Nov 10, 2007·Current Oncology Reports·Maher Karam-Hage, Paul M Cinciripini
May 28, 2005·Journal of Applied Physiology·Hiroshi HasegawaYvette Michotte

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.